Fabiola Vania Felicia
Fakultas Kedokteran Universitas Katolik Atma Jaya, Jakarta, Indonesia

Published : 6 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 6 Documents
Search

Manajemen Laktasi di Masa Pandemi COVID-19 Fabiola Vania Felicia
Cermin Dunia Kedokteran Vol 47, No 11 (2020): Infeksi
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v47i11.1198

Abstract

Pandemi infeksi severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) sudah terbukti dapat menyerang seluruh kelompok masyarakat termasuk ibu hamil dan neonatus. Angka kejadian anak di bawah usia 10 tahun <1% kasus. Neonatus dengan coronavirus disease 2019 (COVID-19) kebanyakan asimtomatik atau klinis ringan. Hingga saat ini, risiko transmisi infeksi SARS-CoV-2 melalui air susu ibu (ASI) masih belum jelas dan belum dapat disingkirkan. Hal ini menyebabkan munculnya keraguan terhadap praktik pemberian ASI. WHO merekomendasikan ibu suspek atau terkonfirmasi COVID-19 untuk tetap menyusui. Manfaat ASI dibandingkan dengan potensi risiko infeksi COVID-19 pada neonatus perlu diketahui, sehingga dapat mendukung berlangsungnya praktik menyusui di masa pandemi ini.Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection pandemic has affected all populations including pregnant women and neonates. Clinical features of neonates with coronavirus disease (COVID-19) are generally mild or asymptomatic. Cases of COVID-19 in children younger than 10 years old were <1 %. To date, the possibility of COVID-19 virus transmission from mothers to their newborns through breastmilk still cannot be ruled out. WHO recommends every mother with confirmed or suspected SARS-CoV-2 infection should be supported to continue or initiate breastfeeding. Mothers should know the advantages of breastfeeding compared to potential risks of COVID-19 transmission, so that continuation of breastfeeding practice could be maintained during pandemic.
Manifestasi Klinis Infeksi COVID-19 pada Anak Fabiola Vania Felicia
Cermin Dunia Kedokteran Vol 47, No 8 (2020): Kardiologi
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v47i8.774

Abstract

Coronavirus Disease 2019 (COVID-19) merupakan penyakit infeksi baru dengan tingkat penyebaran sangat cepat dan saat ini menjadi pandemi. Sampai Juni 2020, tercatat sekitar 8 juta kasus positif COVID-19 di dunia. Penyakit ini disebabkan oleh spesies coronavirus, SARS-CoV-2. COVID-19 ditularkan dari manusia ke manusia dan dapat menginfeksi seluruh kalangan usia. Sebagian besar kasus COVID-19 anak asimptomatik atau bergejala ringan sehingga status infeksi COVID-19 anggota keluarga penting untuk deteksi infeksi COVID-19 pada anak. Konfirmasi kasus pada anak sama halnya pada kasus dewasa dengan pemeriksaan RT-PCR. Prinsip tatalaksana adalah isolasi, terapi suportif, dan simptomatik sesuai kondisi pasien.Coronavirus Disease 2019 (COVID-19) is a new communicable disease that has spread rapidly around the world and causing a global pandemic. As of June 2020, approximately 8 million confirmed cases of COVID-19 have been reported worldwide. This disease is caused by coronavirus species, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 spreads through human-to-human transmission and affected every age group. Most cases of COVID-19 in children were asymptomatic or mild; family clustering is a strong epidemiological link in pediatric COVID-19. Preferred diagnostic test in children is similar to adult, with RT-PCR test. Management is based on clinical conditions, which include self-isolation, supportive therapy, and symptomatic therapy.
Manajemen Laktasi di Masa Pandemi COVID-19 Fabiola Vania Felicia
Cermin Dunia Kedokteran Vol 47 No 9 (2020): Infeksi
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v47i9.568

Abstract

Pandemi infeksi severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) sudah terbukti dapat menyerang seluruh kelompok masyarakattermasuk ibu hamil dan neonatus. Angka kejadian anak di bawah usia 10 tahun <1% kasus. Neonatus dengan coronavirus disease 2019 (COVID-19) kebanyakan asimtomatik atau klinis ringan. Hingga saat ini, risiko transmisi infeksi SARS-CoV-2 melalui air susu ibu (ASI) masih belum jelas dan belum dapat disingkirkan. Hal ini menyebabkan munculnya keraguan terhadap praktik pemberian ASI. WHO merekomendasikan ibu suspek atau terkonfirmasi COVID-19 untuk tetap menyusui. Manfaat ASI dibandingkan dengan potensi risiko infeksi COVID-19 pada neonatus perlu diketahui, sehingga dapat mendukung berlangsungnya praktik menyusui di masa pandemi ini. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection pandemic has affected all populations including pregnant women and neonates. Clinical features of neonates with coronavirus disease (COVID-19) are generally mild or asymptomatic. Cases of COVID-19 in children younger than 10 years old were <1 %. To date, the possibility of COVID-19 virus transmission from mothers to their newborns through breastmilk still cannot be ruled out. WHO recommends every mother with confirmed or suspected SARS-CoV-2 infection should be supported to continue or initiate breastfeeding. Mothers should know the advantages of breastfeeding compared to potential risks of COVID-19 transmission, so that continuation of breastfeeding practice could be maintained during pandemic.
Manifestasi Klinis Infeksi COVID-19 pada Anak Fabiola Vania Felicia
Cermin Dunia Kedokteran Vol 47 No 6 (2020): Kardiologi & Pediatri
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v47i6.619

Abstract

Coronavirus Disease 2019 (COVID-19) merupakan penyakit infeksi baru dengan tingkat penyebaran sangat cepat dan saat ini menjadi pandemi. Sampai Juni 2020, tercatat sekitar 8 juta kasus positif COVID-19 di dunia. Penyakit ini disebabkan oleh spesies coronavirus, SARS-CoV-2. COVID-19 ditularkan dari manusia ke manusia dan dapat menginfeksi seluruh kalangan usia. Sebagian besar kasus COVID-19 anak asimptomatik atau bergejala ringan, sehingga status infeksi COVID-19 anggota keluarga penting untuk deteksi infeksi COVID-19 pada anak. Konfirmasi kasus pada anak sama halnya pada kasus dewasa dengan pemeriksaan RT-PCR. Prinsip tatalaksana adalah isolasi, terapi suportif, dan simptomatik sesuai kondisi pasien. Coronavirus Disease 2019 (COVID-19) is a new communicable disease that has spread rapidly around the world and causing a global pandemic. As of June 2020, approximately 8 million confirmed cases of COVID-19 have been reported worldwide. This disease is caused by coronavirus species, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 spreads through human-to-human transmission and affected every age group. Most cases of COVID-19 in children were asymptomatic or mild; family clustering is a strong epidemiological link in pediatric COVID-19. Preferred diagnostic test in children is similar to adult, with RT-PCR test. Management is based on clinical conditions, which include self-isolation, supportive therapy, and symptomatic therapy.
Manajemen Laktasi di Masa Pandemi COVID-19 Fabiola Vania Felicia
Cermin Dunia Kedokteran Vol 47 No 9 (2020): Infeksi
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v47i9.568

Abstract

Pandemi infeksi severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) sudah terbukti dapat menyerang seluruh kelompok masyarakattermasuk ibu hamil dan neonatus. Angka kejadian anak di bawah usia 10 tahun <1% kasus. Neonatus dengan coronavirus disease 2019 (COVID-19) kebanyakan asimtomatik atau klinis ringan. Hingga saat ini, risiko transmisi infeksi SARS-CoV-2 melalui air susu ibu (ASI) masih belum jelas dan belum dapat disingkirkan. Hal ini menyebabkan munculnya keraguan terhadap praktik pemberian ASI. WHO merekomendasikan ibu suspek atau terkonfirmasi COVID-19 untuk tetap menyusui. Manfaat ASI dibandingkan dengan potensi risiko infeksi COVID-19 pada neonatus perlu diketahui, sehingga dapat mendukung berlangsungnya praktik menyusui di masa pandemi ini. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection pandemic has affected all populations including pregnant women and neonates. Clinical features of neonates with coronavirus disease (COVID-19) are generally mild or asymptomatic. Cases of COVID-19 in children younger than 10 years old were <1 %. To date, the possibility of COVID-19 virus transmission from mothers to their newborns through breastmilk still cannot be ruled out. WHO recommends every mother with confirmed or suspected SARS-CoV-2 infection should be supported to continue or initiate breastfeeding. Mothers should know the advantages of breastfeeding compared to potential risks of COVID-19 transmission, so that continuation of breastfeeding practice could be maintained during pandemic.
Manifestasi Klinis Infeksi COVID-19 pada Anak Fabiola Vania Felicia
Cermin Dunia Kedokteran Vol 47 No 6 (2020): Kardiologi & Pediatri
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v47i6.619

Abstract

Coronavirus Disease 2019 (COVID-19) merupakan penyakit infeksi baru dengan tingkat penyebaran sangat cepat dan saat ini menjadi pandemi. Sampai Juni 2020, tercatat sekitar 8 juta kasus positif COVID-19 di dunia. Penyakit ini disebabkan oleh spesies coronavirus, SARS-CoV-2. COVID-19 ditularkan dari manusia ke manusia dan dapat menginfeksi seluruh kalangan usia. Sebagian besar kasus COVID-19 anak asimptomatik atau bergejala ringan, sehingga status infeksi COVID-19 anggota keluarga penting untuk deteksi infeksi COVID-19 pada anak. Konfirmasi kasus pada anak sama halnya pada kasus dewasa dengan pemeriksaan RT-PCR. Prinsip tatalaksana adalah isolasi, terapi suportif, dan simptomatik sesuai kondisi pasien. Coronavirus Disease 2019 (COVID-19) is a new communicable disease that has spread rapidly around the world and causing a global pandemic. As of June 2020, approximately 8 million confirmed cases of COVID-19 have been reported worldwide. This disease is caused by coronavirus species, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 spreads through human-to-human transmission and affected every age group. Most cases of COVID-19 in children were asymptomatic or mild; family clustering is a strong epidemiological link in pediatric COVID-19. Preferred diagnostic test in children is similar to adult, with RT-PCR test. Management is based on clinical conditions, which include self-isolation, supportive therapy, and symptomatic therapy.